Randomized phase II trial comparing every-3-week carboplatin/paclitaxel (C/P) versus every-3-week C with weekly P in advanced non-small cell lung cancer (NSCLC)
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: H. B. Niell, M. A. Socinski, K. Bakri, J. Wall, M. Baggstrom, M. Escudero, A. Mears, M. Tynan, A. Ivanova
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2275454249